Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$11.81 - $20.92 $41,819 - $74,077
-3,541 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$16.97 - $25.0 $7,229 - $10,650
-426 Reduced 10.74%
3,541 $68,000
Q4 2021

Jan 28, 2022

BUY
$16.22 - $29.69 $64,344 - $117,780
3,967 New
3,967 $94,000

Others Institutions Holding IMGO

About Imago BioSciences, Inc.


  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.